A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice
Published in 2021 by
T. Shapira,
I. A. Monreal,
S. P. Dion,
M. Jager,
A. Désilets,
A. D. Olmstead,
T. Vandal,
D. W. Buchholz,
B. Imbiakha,
G. Gao,
A. Chin,
W. D. Rees,
T. Steiner 
,
I. R. Nabi,
E. Marsault
and other authors.
,
I. R. Nabi,
E. Marsault
and other authors.
